Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Yearbook of Neurology and Neurosurgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0513-5117(09)79035-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

  2004cited by this paper
• Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

  1999cited by this paper

• Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke

  2022cites this paper
• Association of Stress Hyperglycemia Ratio With Acute Ischemic Stroke Outcomes Post-thrombolysis

  2022influential citation
• The association of plasma osteoprotegerin levels and functional outcomes post endovascular thrombectomy in acute ischemic stroke patients: a retrospective observational study

  2022cites this paper
• Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy

  2022cites this paper
• Hemorrhagic Transformation After Ischemic Stroke: Mechanisms and Management

  2021cites this paper
• Robust thrombolytic and anti-inflammatory action of a constitutively active ADAMTS13 variant in murine stroke models

  2021cites this paper
• Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions

  2021cites this paper
• Evaluation of Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis; Experiences of a Stroke Center

  2021cites this paper
• Evidence-Based Updates to Thrombectomy: Targets, New Techniques, and Devices

  2021cites this paper
• Systemic thrombolysis in ischaemic stroke patients with COVID‐19

  2021cites this paper
• Epidemiology and risk factors for stroke in young individuals: implications for prevention

  2021cites this paper
• Ongoing Improvement in Acute Ischemic Stroke Therapy Per Concurrent Guidelines and Easily Implementable Quality Improvement Protocol

  2021cites this paper
• Acute revascularization in ischemic stroke: Updated Swiss guidelines

  2021cites this paper
• Grenzbereiche der Thrombektomie

  2021cites this paper
• Mechanical Thrombectomy in Stroke. Experience from Switching from Stent Retriever Only to Stent Retriever Combined with Aspiration Catheter

  2021cites this paper
• Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats

  2021cites this paper
• Low versus standard dose intravenous alteplase in the treatment of acute ischemic stroke in Egyptian patients

  2021cites this paper
• Nationwide temporal trend analysis of reperfusion therapy utilization and mortality in acute ischemic stroke patients in Japan

  2021cites this paper
• Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation

  2021influential citation
• Efficacy and Safety of Intravenous rtPA in Ischemic Strokes Due to Small-Vessel Occlusion: Systematic Review and Meta-Analysis

  2021cites this paper
• Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window

  2021cites this paper
• POSITIVE: Perfusion imaging selection of ischemic stroke patients for endovascular therapy

  2021cites this paper
• Intracranial Bleeding After Reperfusion Therapy in Acute Ischemic Stroke

  2021cites this paper
• Neuroprotective effect of hypoxic preconditioning and neuronal activation in a in vitro human model of the ischemic penumbra

  2021cites this paper
• Hub-and-spoke model for thrombectomy service in UK NHS practice.

  2021cites this paper
• Neuroprotective effects of Ginkgolide B in focal cerebral ischemia through selective activation of prostaglandin E2 receptor EP4 and the downstream transactivation of epidermal growth factor receptor

  2021cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Desmoteplase

  2021cites this paper
• To Treat or Not to Treat: Importance of Functional Dependence in Deciding Intravenous Thrombolysis of “Mild Stroke” Patients

  2020cites this paper
• Therapeutic effectiveness of Limonium gmelinii extract in experimentally – induced ischemic brain damage in vivo

  2020cites this paper
• THE UTILIZATION OF GOLDEN PERIOD OF ISCHEMIC STROKE IN PATIENTS IN PRODUCTIVE AGES

  2020cites this paper
• ADMISSÃO DE PACIENTES COM ACIDENTE VASCULAR CEREBRAL EM HOSPITAL PÚBLICO

  2020cites this paper
• Treatment with Delipid Extracorporeal Lipoprotein Filter from Plasma after Intravenous Thrombolysis for Acute Ischemic Stroke: A Single-Center Experience

  2020cites this paper
• Cerebral Thrombolysis in Rural Residents Aged ≥ 80

  2020cites this paper
• How Long Are Reperfusion Therapies Beneficial for Patients after Stroke Onset? Lessons from Lethal Ischemia Following Early Reperfusion in a Mouse Model of Stroke

  2020cites this paper
• Combined Treatment With 2-(2-Benzofu-Ranyl)-2-Imidazoline and Recombinant Tissue Plasminogen Activator Protects Blood–Brain Barrier Integrity in a Rat Model of Embolic Middle Cerebral Artery Occlusion

  2020influential citation
• CJEM Debate Series: #TPA should be the initial treatment in eligible patients presenting with an acute ischemic stroke.

  2020cites this paper
• Pharmacokinetics, pharmacodynamics, safety, tolerability, and mass balance of single and continuous intravenous infusion of SPT-07A in healthy volunteers

  2020cites this paper
• Efficiency of telemedicine for acute stroke: a cost-effectiveness analysis from a French pilot study

  2020cites this paper
• Similar thrombolysis outcomes in acute stroke patients with and without atrial fibrillation if pre-stroke CHA2DS2-VASc score is low

  2020cites this paper
• A New Era of Extended Time Window Acute Stroke Interventions Guided by Imaging

  2020cites this paper
• Optical spectroscopy and microscopy techniques for assessment of neurological diseases

  2020cites this paper
• Retrospective Review and Proof of Concept of Asia’s First Mobile Stroke Unit Experience in Kovai Medical Center and Hospital

  2020cites this paper
• High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects

  2020cites this paper
• Role of acute‐phase protein ORM in a mice model of ischemic stroke

  2019cites this paper
• Number Needed to Treat with Vertebral Augmentation to Save a Life

  2019cites this paper
• EPO and TMBIM3/GRINA Promote the Activation of the Adaptive Arm and Counteract the Terminal Arm of the Unfolded Protein Response after Murine Transient Cerebral Ischemia

  2019cites this paper
• Carotid duplex parameters to predict long term outcomes of ischemic stroke patients receiving intra-arterial thrombectomy treatment

  2019cites this paper
• Individualized quantification of the benefit from reperfusion therapy using stroke predictive models

  2019cites this paper
• Comparative efficacy and safety of bridging strategies with direct mechanical thrombectomy in large vessel occlusion

  2019cites this paper
• Acute diffuse and transient thyroid swelling after intravenous thrombolysis for acute ischemic stroke

  2018cites this paper
• Early Acute Ischemic Stroke Management for Pharmacists

  2018cites this paper
• Protective effects of paeonol on subacute/chronic brain injury during cerebral ischemia in rats

  2018cites this paper
• Serum lipid level is not associated with symptomatic intracerebral hemorrhage after intravenous thrombolysis for acute ischemic stroke

  2018cites this paper
• Immediate remote ischemic postconditioning reduces cerebral damage in ischemic stroke mice by enhancing leptomeningeal collateral circulation

  2018cites this paper
• Thrombolyse intraveineuse dans les infarctus cérébraux aigus dans un centre sans unité neurovasculaire : expérience du centre hospitalier de Cayenne

  2017influential citation
• Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate

  2017cites this paper
• Management of hyper-acute Ischaemic Stroke: Current status, challenges and opportunities in Northern Sri Lanka

  2016cites this paper
• Exosomes in stroke pathogenesis and therapy.

  2016cites this paper
• mHealth For Aging China: Opportunities and Challenges.

  2016cites this paper
• Imaging-based selection for revascularization in acute ischemic stroke.

  2016cites this paper
• Safety and Efficacy of Mechanical Thrombectomy Using Stent Retrievers in the Endovascular Treatment of Acute Ischaemic Stroke: A Systematic Review

  2015cites this paper
• Revisiting the "Golden Hour": An Evaluation of Out-of-Hospital Time in Shock and Traumatic Brain Injury.

  2015cites this paper
• Safety of intravenous thrombolysis for acute ischaemic stroke including concomitant neoplastic disease sufferers – experience from Poland

  2015cites this paper
• Cognitive recovery in acute stroke: Measurement and facilitation of change

  2015cites this paper
• A novel snake venom‐derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury

  2015influential citation
• Implementation of Computerized Physician Order Entry Is Associated With Increased Thrombolytic Administration for Emergency Department Patients With Acute Ischemic Stroke.

  2015cites this paper
• lessons learnt from the Stroke 90 Project − − Reducing delay to stroke thrombolysis

  2015cites this paper
• Diabetes and thrombolysis for acute stroke: a clear benefit for diabetics

  2014cites this paper
• Outcome Prediction in Acute Stroke Patients Considered for Endovascular Treatment: A Novel Tool

  2014cites this paper
• Endovascular treatment of tandem vascular occlusions in acute ischemic stroke

  2014cites this paper
• Magnetic Resonance Imaging of Stroke in the Rat.

  2014cites this paper
• Intravenous thrombolysis in patients aged more than 80 years in the three rural hospitals in southeast Poland: An observational study

  2014cites this paper
• Comparison of stent retriever and intra‐arterial fibrinolysis in patients with acute ischaemic stroke

  2014cites this paper
• Discharge disposition to skilled nursing facility after endovascular reperfusion therapy predicts a poor prognosis

  2014cites this paper
• Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat

  2014influential citation
• Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 Minutes

  2014cites this paper
• Drug-Induced Hypothermia as Beneficial Treatment before and after Cerebral Ischemia

  2013cites this paper
• Pyruvate minimizes rtPA toxicity from in vitro oxygen-glucose deprivation and reoxygenation.

  2013influential citation
• ‘Time’ for success

  2013cites this paper
• Chinese Medicine NeuroAiD Efficacy Stroke Recovery - Extension Study (CHIMES-E Study): An Observational Multicenter Study to Investigate the Longer-Term Efficacy of NeuroAiD in Stroke Recovery

  2013cites this paper
• Reducing delay to stroke thrombolysis—lessons learnt from the Stroke 90 Project

  2013cites this paper
• Magnetic Resonance Imaging-Based versus Computed Tomography-Based Thrombolysis in Acute Ischemic Stroke: Comparison of Safety and Efficacy within a Cohort Study

  2013cites this paper
• A Consecutive and Prospective Stroke Database Covers the State of Baden-Wuerttemberg with 10.8 Million Inhabitants in Germany

  2013cites this paper
• Adapting the Computed Tomography Criteria of Hemorrhagic Transformation to Stroke Magnetic Resonance Imaging

  2013cites this paper
• Good Times - Bad Times: My Story regarding Acute Stroke Treatment

  2013cites this paper
• Overcoming the evening/weekend effects on time delays and outcomes of endovascular stroke therapy: the Calgary Stroke Program experience

  2013cites this paper
• Ischemia-Reperfusion Injury in Stroke

  2013cites this paper
• Chinese Guidelines for Endovascular Management of Ischemic Cerebrovascular Diseases

  2013cites this paper
• Rural Victorian Telestroke project

  2012cites this paper
• Diabetes and previous stroke: hazards for intravenous thrombolysis?

  2012cites this paper
• Therapeutic effects of tetramethylpyrazine nitrone in rat ischemic stroke models

  2012influential citation
• Intravenous thrombolysis in young stroke patients

  2012cites this paper
• Multimodal CT Imaging and Recanalizing Therapy in Acute Ischemic Stroke: Retrospective Analysis of a One-Year Single-Center Experience

  2012cites this paper
• Utilization of Intravenous Thrombolysis in 3–4.5 Hours: Analysis of the Minnesota Stroke Registry

  2012cites this paper
• Emerging treatments for acute ischemic stroke include use of thrombolytic and neuroprotective agents

  2012influential citation
• Vascular protection to increase the safety of tissue plasminogen activator for stroke.

  2012influential citation
• tPA for stroke – Are we ready to remove the barriers?

  2012cites this paper
• Cerebral blood flow alteration in neuroprotection following cerebral ischaemia

  2011influential citation
• Preclinical stroke research – advantages and disadvantages of the most common rodent models of focal ischaemia

  2011influential citation
• Анализ 'затраты-эффективность' при лечении 'новыми' противоэпилептическими препаратами

  2011cites this paper